US Pre-Market SEC Filings Roundup — January 13, 2026

14-01-2026

Incannex Healthcare Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001213900-26-004158, Size: 248 KB) disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Sector is not specified. No details on the specific events, transactions, financial statements, or exhibits are provided in the summary.

14-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001493152-26-002113), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or exhibits are disclosed in the provided filing summary. Sector not specified.

14-01-2026

SemiLEDs Corp filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012216), reporting results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative details are disclosed in the provided filing summary. This is a standard financial results disclosure with sector not specified.

14-01-2026

PROVIDENT FINANCIAL SERVICES INC filed a Form 8-K on January 14, 2026 (AccNo: 0001628280-26-001994, Size: 3 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative financial metrics are disclosed. Sector is not specified.

14-01-2026

Palladyne AI Corp. filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012228, size: 14 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information and attached exhibits. No details on the core event, transaction values, financial metrics, or exhibit contents are explicitly stated in the provided filing summary.

14-01-2026

Funko, Inc. disclosed an officer change via SEC Form 8-K filed on January 14, 2026 (AccNo: 0001193125-26-012212, Size: 132 KB) under Item 5.02, covering departures, elections, appointments of directors or certain officers, and compensatory arrangements. No specific details on the affected officer, position, reason, or terms are provided in the available information. Sector not specified.

14-01-2026

Forge Global Holdings, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001827821-26-000002, Size: 202 KB), reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

14-01-2026

Playtika Holding Corp. filed an 8-K on January 14, 2026 (AccNo: 0001828016-26-000003, Size: 559 KB), reporting costs associated with exit or disposal activities under Item 2.05, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific transaction values, financial metrics, or quantitative details are disclosed in the provided filing summary. This is a multi-item filing combining mandatory and voluntary disclosures.

14-01-2026

Fifth Third Bancorp filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-011977, Size: 277 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

14-01-2026

Comerica Inc filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012057, Size: 242 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, or exhibits are provided in the filing summary. Sector not specified.

14-01-2026

News Corp filed a Form 8-K on January 14, 2026 (AccNo: 0001564708-26-000009, size 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

14-01-2026

cbdMD, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001437749-26-001219, Size: 603 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or other quantitative data disclosed in the provided summary. Sector is not specified.

14-01-2026

The company filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012000, Size: 125 KB) disclosing an Other Event under Item 8.01. No specific details on the event, transaction, or financial impacts are provided in the filing summary. Sector is not specified.

14-01-2026

SharonAI Holdings, Inc. filed an 8-K on January 14, 2026 (AccNo: 0001829126-26-000288, Size: 280 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 5.02 departure/election/appointment of directors or certain officers including compensatory arrangements, and Item 9.01 financial statements and exhibits. No specific details on the agreement, personnel changes, transaction values, or financial metrics are disclosed in the provided summary. Sector is not specified.

14-01-2026

ClearOne Inc filed a Form 8-K on January 14, 2026 (AccNo: 0001753926-26-000105, Size: 249 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure for a material event, but core details of the agreement, transaction value, parties involved, or financial impacts are NOT_DISCLOSED. Sector not specified.

14-01-2026

Jefferies Financial Group Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001140361-26-001121, size 251 KB), disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

14-01-2026

Arcadia Biosciences, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012028, Size: 769 KB), reporting a multi-item disclosure including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on the core event, transaction values, share counts, strategic importance, or financial impacts are disclosed in the provided filing summary.

14-01-2026

Biogen Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0000875045-26-000003, Size: 202 KB) under Item 2.02 reporting results of operations and financial condition. Sector not specified. No specific financial metrics, transaction details, or quantitative data disclosed in the provided filing information.

14-01-2026

Wingstop Inc. disclosed an officer change via Form 8-K filed on January 14, 2026 (AccNo: 0001636222-26-000003, Size: 149 KB), under Item 5.02 covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the available information. Sector is not specified.

14-01-2026

Wells Fargo & Company/MN filed a Form 8-K on January 14, 2026 (AccNo: 0000072971-26-000009, Size: 8 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.

14-01-2026

Nuvalent, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012243, Size: 257 KB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This constitutes a financial results disclosure with no specific revenue, earnings, transaction values, or other quantitative metrics mentioned. Sector is not specified.

14-01-2026

Bank of America Corp /DE/ filed a Form 8-K on January 14, 2026 (AccNo: 0000070858-26-000020, Size: 16 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure with no specific numerical financial metrics, transaction values, or detailed outcomes provided in the filing summary. The event type is Financial Results from the US market.

14-01-2026

MagnaChip Semiconductor Corp filed an 8-K on January 14, 2026 (AccNo: 0001193125-26-012251, Size: 159 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Event sourced from US SEC, sector not specified.

14-01-2026

Perspective Therapeutics, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012259, size: 11 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

14-01-2026

New Horizon Aircraft Ltd. filed a Form 8-K on January 14, 2026 (AccNo: 0001213900-26-004156, Size: 265 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

14-01-2026

Coca-Cola Co filed a Form 8-K on January 14, 2026 (AccNo: 0001552781-26-000017, Size: 982 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 covers Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the filing summary.

14-01-2026

Labcorp Holdings Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0000920148-26-000009, Size: 155 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative impacts are specified in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

14-01-2026

C4 Therapeutics, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001628280-26-002010, Size: 195 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the filing summary. All specific impacts, values, and entities beyond the filer are NOT_DISCLOSED.

14-01-2026

Entegris Inc filed a Form 8-K on January 14, 2026, reporting under Item 8.01 Other Events. Accession number: 0001101302-26-000003. Filing size: 276 KB; no specific event details, transaction values, or financial metrics disclosed.

14-01-2026

Flutter Entertainment plc filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012264, size 144 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.

14-01-2026

DENTSPLY SIRONA Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0000818479-26-000043, size: 644 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or exhibits are provided in the filing summary. Sector not specified.

14-01-2026

AngioDynamics Inc filed a Form 8-K on January 14, 2026 (AccNo: 0001140361-26-001154, Size: 3 MB) under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material non-public information with attached exhibits. No specific event details, financial metrics, or transaction data are disclosed in the provided filing summary.

14-01-2026

UNITED COMMUNITY BANKS INC filed an 8-K on January 14, 2026 (AccNo: 0001104659-26-003548, Size: 24 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results with no specific numerical financial metrics, transaction values, or other quantitative data disclosed in the provided information. Sector not specified.

14-01-2026

Sypris Solutions Inc filed a Form 8-K on January 14, 2026 (AccNo: 0001437749-26-001220), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No transaction values, parties, financial metrics, or other quantitative details are provided in the filing summary.

14-01-2026

NOCERA, INC. filed a Form 8-K on January 14, 2026 (AccNo: 0001683168-26-000278), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No details on the specific matters submitted, vote outcomes, or any quantitative data are disclosed in the provided filing summary. This is a standard informational disclosure with no apparent material financial or strategic implications evident.

14-01-2026

Vocodia Holdings Corp filed a Form 8-K on January 14, 2026 (AccNo: 0001493152-26-002129, Size: 209 KB), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.02 Unregistered Sales of Equity Securities. No specific details on the agreement, transaction value, parties, share counts, or financial impacts are disclosed in the provided information. Sector not specified.

14-01-2026

Establishment Labs Holdings Inc. filed a Form 8-K on January 14, 2026, disclosing information under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the content of the Regulation FD disclosure or exhibits are provided in the filing summary. This is a multi-item voluntary filing with no quantitative data or transaction details mentioned.

14-01-2026

XTI Aerospace, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001213900-26-004167, Size: 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

14-01-2026

Industrial Logistics Properties Trust filed a Form 8-K on January 14, 2026 (AccNo: 0001104659-26-003557, Size: 189 KB) under Item 2.02 reporting Results of Operations and Financial Condition. Sector is not specified. No specific financial metrics, transaction values, or quantitative details are disclosed in the provided filing summary.

14-01-2026

Diversified Healthcare Trust filed an 8-K on January 14, 2026 (AccNo: 0001104659-26-003559, Size: 251 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 8.01 Other Events. No specific financial metrics, transaction details, or numerical values are disclosed in the provided filing summary. This is a financial results announcement from the US market.

14-01-2026

ScanTech AI Systems Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001104659-26-003558, Size: 227 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the filing summary provided. This appears to be a multi-item voluntary disclosure with attached exhibits.

14-01-2026

CBIZ, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012290, Size: 134 KB), disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected officers, positions, reasons for change, appointments, resignations, or compensation are stated. Sector is not specified.

14-01-2026

RAPT Therapeutics, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012284, Size: 11 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving voluntary Regulation FD disclosure with attached exhibits. No specific event details, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary.

14-01-2026

LivaNova PLC filed a Form 8-K on January 14, 2026 (AccNo: 0001639691-26-000002, Size: 229 KB), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any involved individuals are NOT_DISCLOSED. No quantitative data, financial metrics, or further context is provided in the filing summary.

14-01-2026

Aveanna Healthcare Holdings, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012301), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary. This is a multi-item filing related to financial results.

14-01-2026

ImmunityBio, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001326110-26-000004, Size: 296 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financials, or quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with exhibits attached.

14-01-2026

KULR Technology Group, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001104659-26-003564, Size: 222 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.

14-01-2026

Armstrong World Industries Inc filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012306, Size: 380 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change; sector not specified. No specific details on the officer, position, reason, or quantitative impacts are disclosed.

14-01-2026

Clover Health Investments, Corp. (/DE) filed a Form 8-K on January 14, 2026 (AccNo: 0001801170-26-000020, Size: 7 MB) under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with sector not specified. No details on the core event, financial data, transactions, or exhibits are disclosed in the provided filing summary.